Don't forget to register to see the latest information being shared in our traditional GIST 101 presentation with Dr. David Josephy and through several panels featuring top GIST specialists and researchers plus a program targeted to the SDH community. https://t.co/pK1Mk8HUXQ
We are excited to announce Health Canada’s authorization of QINLOCK™ via the U.S. FDA’s Project Orbis initiative. We look forward to bringing this important new therapy to eligible patients in Canada. https://t.co/vd26z9Az1t
#Deciphera
Today, we received @US_FDA approval for the treatment of adults with unresectable or metastatic gastrointestinal stromal tumor (#GIST) harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutations. Learn more: https://t.co/Y2gVoS5nLj
$DCPH also presented data at #Targets19 from the Ph. 1 study of ripretinib & the Ph. 1 study of DCC-3014, an oral inhibitor of CSF1R, in patients with advanced solid tumors. Read more here: https://t.co/waDolqBPF1
LRG's #RealWorldEvidence Team including lead author Jerry Call, Dr. Yu Wang, Denisse Montoya and Norman Scherzer, along with Dr. Michael Heinrich of OHSU, have published a study on the impact of treatments beyond first line in #GIST on #Overallsurvival. https://t.co/RvReA7ZoWd
Join Life Raft Group Canada at our next regional meeting in Toronto on March 31st. There will be a round table discussion, presentation, and Q&A on #GIST. For more information and registration: https://t.co/4diUWGe4BK
Dr. Michael Heinrich from the OHSU Knight Cancer Institute will be the keynote speaker at the #GIST Day of Learning in Vancouver on April 27th. Register for the event at https://t.co/0aJrqZUSDg
Make a $35 donation to GIST Sarcoma Life Raft Group Canada and receive a GIST Busters T-shirt as as gift! https://t.co/0YNPQ0leHO #GIST#Sarcoma#Cancer#Donate
GIST Day of Learning coming to Halifax (May 26) and Fredericton (May 27) more info on our website https://t.co/PjD9LfAO9u #GDOL#maritimes#gistcancer#raredisease